AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 184 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,328,000 | +9.3% | 90,000 | 0.0% | 0.28% | -14.6% |
| Q1 2020 | $1,215,000 | -16.2% | 90,000 | +50.0% | 0.32% | +11.4% |
| Q4 2019 | $1,450,000 | +25.8% | 60,000 | 0.0% | 0.29% | +13.8% |
| Q3 2019 | $1,153,000 | -35.0% | 60,000 | 0.0% | 0.25% | -31.9% |
| Q2 2019 | $1,773,000 | -37.8% | 60,000 | 0.0% | 0.37% | -40.8% |
| Q1 2019 | $2,850,000 | +74.3% | 60,000 | +32.5% | 0.63% | +54.4% |
| Q4 2018 | $1,635,000 | -41.4% | 45,300 | 0.0% | 0.41% | -28.5% |
| Q3 2018 | $2,788,000 | -8.9% | 45,300 | 0.0% | 0.57% | -15.2% |
| Q2 2018 | $3,060,000 | +24.5% | 45,300 | 0.0% | 0.67% | +23.3% |
| Q1 2018 | $2,458,000 | -9.2% | 45,300 | 0.0% | 0.55% | -9.0% |
| Q4 2017 | $2,707,000 | +22.9% | 45,300 | 0.0% | 0.60% | +15.8% |
| Q3 2017 | $2,202,000 | -7.5% | 45,300 | 0.0% | 0.52% | -13.7% |
| Q2 2017 | $2,381,000 | – | 45,300 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |